Viewing Study NCT07297550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2026-05-25 @ 5:29 AM
Study NCT ID: NCT07297550
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Aplastic Anemia View
None Refractory Aplastic Anemia View
None Newly Diagnosed Aplastic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JAK1 inhibitor View
None Intensive immunosuppressive therapy View